Teng Chong, Tong Zhicheng, He Qiulin, Zhu Huangrong, Wang Lu, Zhang Xianzhu, Wei Wei
Department of Orthopaedic Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 32200, China.
Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310058, China.
Gels. 2022 Apr 29;8(5):275. doi: 10.3390/gels8050275.
The repair of large bone defects in clinic is a challenge and urgently needs to be solved. Tissue engineering is a promising therapeutic strategy for bone defect repair. In this study, hydrogel microspheres (HMs) were fabricated to act as carriers for bone marrow mesenchymal stem cells (BMSCs) to adhere and proliferate. The HMs were produced by a microfluidic system based on light-induced gelatin of gelatin methacrylate (GelMA). The HMs were demonstrated to be biocompatible and non-cytotoxic to stem cells. More importantly, the HMs promoted the osteogenic differentiation of stem cells. In vivo, the ability of bone regeneration was studied by way of implanting a BMSC/HM system in the cranial defect of rats for 8 weeks. The results confirmed that the BMSC/HM system can induce superior bone regeneration compared with both the HMs alone group and the untreated control group. This study provides a simple and effective research idea for bone defect repair, and the subsequent optimization study of HMs will provide a carrier material with application prospects for tissue engineering in the future.
临床上大骨缺损的修复是一项挑战,亟待解决。组织工程是一种有前景的骨缺损修复治疗策略。在本研究中,制备了水凝胶微球(HMs)作为骨髓间充质干细胞(BMSCs)黏附与增殖的载体。HMs由基于甲基丙烯酸明胶(GelMA)光诱导明胶的微流控系统制备而成。已证明HMs具有生物相容性且对干细胞无细胞毒性。更重要的是,HMs促进了干细胞的成骨分化。在体内,通过将BMSC/HM系统植入大鼠颅骨缺损处8周来研究骨再生能力。结果证实,与单独的HMs组和未处理的对照组相比,BMSC/HM系统能诱导出更优的骨再生。本研究为骨缺损修复提供了一种简单有效的研究思路,后续对HMs的优化研究将为未来组织工程提供一种具有应用前景的载体材料。